Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 480-495, September 2007

Tumor risk in disorders of sex development (DSD)

  • Leendert H.J. Looijenga (Professor, Biologist, Head Research)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel./Fax: +31 10 4088329/65.

Department of Pathology, Erasmus MC – University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Building Be, Room 430b, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands

Department of Pediatric Endocrinology and Urology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium

Department of Pediatric Endocrinology Erasmus MC – University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Building Be, Room 430b, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands

Department of Pediatric Pediatric Urology Erasmus MC – University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Building Be, room 430b, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00038-3

doi:10.1016/j.beem.2007.05.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 480-495, September 2007

Article Tools

* Image Usage & Resolution